CCN4 and neoplasm: Our previous study demonstrated that WISP-1-STAT1 signaling contributes to the inhibitory effects of ApoSQ-CAF CM on tumor growth and lung metastasis, as shown using the STAT1 inhibitor fludarabine 23.